{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:31:49Z","timestamp":1788993109461,"version":"build-2803163510"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,12,14]],"date-time":"2016-12-14T00:00:00Z","timestamp":1481673600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"grant \u201eDepression-mechanisms-therapy\u201d","award":["POIG.01.01.02-12-004\/09"],"award-info":[{"award-number":["POIG.01.01.02-12-004\/09"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s00213-016-4495-3","type":"journal-article","created":{"date-parts":[[2016,12,14]],"date-time":"2016-12-14T07:06:04Z","timestamp":1481699164000},"page":"631-645","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Antidepressant-like activity of the neuropeptide Y Y5 receptor antagonist Lu AA33810: behavioral, molecular, and immunohistochemical evidence"],"prefix":"10.1007","volume":"234","author":[{"given":"Helena","family":"Domin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadeta","family":"Szewczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart\u0142omiej","family":"Pochwat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Wo\u017aniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"\u015amia\u0142owska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,14]]},"reference":[{"key":"4495_CR1","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1176\/ajp.150.11.1731","volume":"150","author":"CA Altamura","year":"1993","unstructured":"Altamura CA, Mauri MC, Ferrara A, Moro AR, D'Andrea G, Zamberlan F (1993) Plasma and platelet excitatory amino acids in psychiatric disorders. Am J Psychiatry 150:1731\u20131733","journal-title":"Am J Psychiatry"},{"key":"4495_CR2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0165-6147(99)01309-7","volume":"20","author":"CA Altar","year":"1999","unstructured":"Altar CA (1999) Neurotrophins and depression. Trends Pharmacol Sci 20:59\u201361","journal-title":"Trends Pharmacol Sci"},{"key":"4495_CR3","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0006-3223(03)00073-8","volume":"54","author":"CA Altar","year":"2003","unstructured":"Altar CA, Whitehead RE, Chen R, W\u00f6rtwein G, Madsen TM (2003) Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain. Biol Psychiatry 54:703\u2013709","journal-title":"Biol Psychiatry"},{"key":"4495_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1098-1136(200010)32:1<1::AID-GLIA10>3.0.CO;2-W","volume":"32","author":"CM Anderson","year":"2000","unstructured":"Anderson CM, Swanson RA (2000) Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 32:1\u201314","journal-title":"Glia"},{"key":"4495_CR5","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0166-2236(98)01349-6","volume":"22","author":"A Araque","year":"1999","unstructured":"Araque A, Parpura V, Sanzgiri RP, Haydon PG (1999) Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci 22:208\u2013215","journal-title":"Trends Neurosci"},{"key":"4495_CR6","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1124\/pr.111.005108","volume":"64","author":"AE Autry","year":"2012","unstructured":"Autry AE, Monteggia LM (2012) Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev 64:238\u2013258","journal-title":"Pharmacol Rev"},{"key":"4495_CR7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/mp.2008.106","volume":"15","author":"M Banasr","year":"2010","unstructured":"Banasr M, Chowdhury GM, Terwilliger R, Newton SS, Duman RS, Behar KL, Sanacora G (2010) Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole. Mol Psychiatry 15:501\u2013511","journal-title":"Mol Psychiatry"},{"key":"4495_CR8","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.biopsych.2008.06.008","volume":"64","author":"M Banasr","year":"2008","unstructured":"Banasr M, Duman RS (2008) Glial loss in the prefrontal cortex is sufficient to induce depressive-like behaviors. Biol Psychiatry 64:863\u2013870","journal-title":"Biol Psychiatry"},{"key":"4495_CR9","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00213-014-3730-z","volume":"232","author":"A Bari","year":"2015","unstructured":"Bari A, Dec A, Lee AW, Lee J, Song D, Dale E, Peterson J, Zorn S, Huang X, Campbell B, Robbins TW, West AR (2015) Enhanced inhibitory control by neuropeptide Y Y5 receptor blockade in rats. Psychopharmacology 232:959\u2013973","journal-title":"Psychopharmacology"},{"key":"4495_CR10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJMra073096","volume":"358","author":"RH Belmaker","year":"2008","unstructured":"Belmaker RH, Agam G (2008) Major depressive disorder. N Engl J Med 358:55\u201368","journal-title":"N Engl J Med"},{"key":"4495_CR11","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1017\/S1461145708009309","volume":"11","author":"AR Brunoni","year":"2008","unstructured":"Brunoni AR, Lopes M, Fregni F (2008) A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacol 11:1169\u20131180","journal-title":"Int J Neuropsychopharmacol"},{"key":"4495_CR12","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1177\/0269881111424456","volume":"26","author":"J Budni","year":"2012","unstructured":"Budni J, Lobato KR, Binfar\u00e9 RW, Freitas AE, Costa AP, Mart\u00edn-de-Saavedra MD, Leal RB, Lopez MG, Rodrigues AL (2012) Involvement of PI3K, GSK-3\u03b2 and PPAR\u03b3 in the antidepressant-like effect of folic acid in the forced swimming test in mice. J Psychopharmacol 26:714\u2013723","journal-title":"J Psychopharmacol"},{"key":"4495_CR13","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1097\/00001756-199906030-00022","volume":"10","author":"L Caberlotto","year":"1999","unstructured":"Caberlotto L, Hurd YL (1999) Reduced neuropeptide Y mRNA expression in the prefrontal cortex of subjects with bipolar disorder. Neuroreport 10:1747\u20131750","journal-title":"Neuroreport"},{"key":"4495_CR14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3940(99)00234-7","volume":"265","author":"L Caberlotto","year":"1999","unstructured":"Caberlotto L, Jimenez P, Overstreet DH, Hurd YL, Math\u00e9 AA, Fuxe K (1999) Alterations in neuropeptide Y levels and Y1 binding sites in the flinders sensitive line rats, a genetic animal model of depression. Neurosci Lett 265:191\u2013194","journal-title":"Neurosci Lett"},{"key":"4495_CR15","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1017\/S1092852912000971","volume":"18","author":"M Catena-Dell'Osso","year":"2013","unstructured":"Catena-Dell'Osso M, Fagiolini A, Rotella F, Baroni S, Marazziti D (2013) Glutamate system as target for development of novel antidepressants. CNS Spectr 18:188\u2013198","journal-title":"CNS Spectr"},{"key":"4495_CR16","first-page":"H1737","volume":"273","author":"X Chen","year":"1997","unstructured":"Chen X, DiMaggio DA, Han SP, Westfall TC (1997) Autoreceptor-induced inhibition of neuropeptide Y release from PC-12 cells is mediated by Y2 receptors. Am J Phys 273:H1737\u2013H1744","journal-title":"Am J Phys"},{"key":"4495_CR17","doi-asserted-by":"crossref","first-page":"15653","DOI":"10.1073\/pnas.0507901102","volume":"102","author":"PV Choudary","year":"2005","unstructured":"Choudary PV, Molnar M, Evans SJ, Tomita H, Li JZ, Vawter MP, Myers RM, Bunney WE, Jr Akil H, Watson SJ, Jones EG (2005) Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci U S A 102:15653\u201315658","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4495_CR18","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/0306-4522(85)90260-X","volume":"15","author":"BM Chronwall","year":"1985","unstructured":"Chronwall BM, DiMaggio DA, Massari VJ, Pickel VM, Ruggiero DA, O\u2019Donohue TL (1985) The anatomy of neuropeptide-Y-containing neurons in rat brain. Neuroscience 15:1159\u20131181","journal-title":"Neuroscience"},{"key":"4495_CR19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.neuroscience.2015.12.044","volume":"316","author":"JA Cobb","year":"2016","unstructured":"Cobb JA, O'Neill K, Milner J, Mahajan GJ, Lawrence TJ, May WL, Miguel-Hidalgo J, Rajkowska G, Stockmeier CA (2016) Density of GFAP-immunoreactive astrocytes is decreased in left hippocampi in major depressive disorder. Neuroscience 316:209\u2013220","journal-title":"Neuroscience"},{"key":"4495_CR20","first-page":"1","volume":"27","author":"CW Cotman","year":"1981","unstructured":"Cotman CW, Foster A, Lanthorn T (1981) An overview of glutamate as a neurotransmitter. Adv Biochem Psychopharmacol 27:1\u201327","journal-title":"Adv Biochem Psychopharmacol"},{"key":"4495_CR21","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/cercor\/12.4.386","volume":"12","author":"D Cotter","year":"2002","unstructured":"Cotter D, Mackay D, Chana G, Beasley C, Landau S, Everall IP (2002) Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cereb Cortex 12:386\u2013394","journal-title":"Cereb Cortex"},{"key":"4495_CR22","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archpsyc.58.6.545","volume":"58","author":"D Cotter","year":"2001","unstructured":"Cotter D, Mackay D, Landau S, Kerwin R, Everall I (2001) Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch Gen Psychiatry 58:545\u2013553","journal-title":"Arch Gen Psychiatry"},{"key":"4495_CR23","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","volume":"23","author":"JF Cryan","year":"2002","unstructured":"Cryan JF, Markou A, Lucki I (2002) Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 23:238\u2013245","journal-title":"Trends Pharmacol Sci"},{"key":"4495_CR24","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00213-005-0093-5","volume":"182","author":"JF Cryan","year":"2005","unstructured":"Cryan JF, Page ME, Lucki I (2005) Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment. Psychopharmacology 182:335\u2013344","journal-title":"Psychopharmacology"},{"key":"4495_CR25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.euroneuro.2012.04.017","volume":"23","author":"B Cz\u00e9h","year":"2013","unstructured":"Cz\u00e9h B, Di Benedetto B (2013) Antidepressants act directly on astrocytes: evidences and functional consequences. Eur Neuropsychopharmacol 23:171\u2013185","journal-title":"Eur Neuropsychopharmacol"},{"key":"4495_CR26","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.neuroscience.2014.07.062","volume":"277","author":"SJ Desai","year":"2014","unstructured":"Desai SJ, Borkar CD, Nakhate KT, Subhedar NK, Kokare DM (2014) Neuropeptide Y attenuates anxiety- and depression-like effects of cholecystokinin-4 in mice. Neuroscience 277:818\u2013830","journal-title":"Neuroscience"},{"key":"4495_CR27","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02245592","volume":"121","author":"MJ Detke","year":"1995","unstructured":"Detke MJ, Rickels M, Lucki I (1995) Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 121:66\u201372","journal-title":"Psychopharmacology"},{"key":"4495_CR28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.neuroscience.2012.11.061","volume":"232","author":"B Di Benedetto","year":"2013","unstructured":"Di Benedetto B, Radecke J, Schmidt MV, Rupprecht R (2013) Acute antidepressant treatment differently modulates ERK\/MAPK activation in neurons and astrocytes of the adult mouse prefrontal cortex. Neuroscience 232:161\u2013168","journal-title":"Neuroscience"},{"key":"4495_CR29","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0028-3908(03)00198-9","volume":"45","author":"BG Dias","year":"2003","unstructured":"Dias BG, Banerjee SB, Duman RS, Vaidya VA (2003) Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain. Neuropharmacology 45:553\u2013563","journal-title":"Neuropharmacology"},{"key":"4495_CR30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bbr.2014.07.019","volume":"273","author":"H Domin","year":"2014","unstructured":"Domin H, Szewczyk B, Wo\u017aniak M, Wawrzak-Wlecia\u0142 A, \u015amia\u0142owska M (2014) Antidepressant-like effect of the mGluR5 antagonist MTEP in an astroglial degeneration model of depression. Behav Brain Res 273:23\u201333","journal-title":"Behav Brain Res"},{"key":"4495_CR31","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.neuropharm.2011.07.017","volume":"62","author":"N Dreim\u00fcller","year":"2012","unstructured":"Dreim\u00fcller N, Schlicht KF, Wagner S, Peetz D, Borysenko L, Hiemke C, Lieb K, Tadi\u0107 A (2012) Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with major depression. Neuropharmacology 62:264\u2013269","journal-title":"Neuropharmacology"},{"key":"4495_CR32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1242\/jeb.107086","volume":"218","author":"F Duclot","year":"2015","unstructured":"Duclot F, Kabbaj M (2015) Epigenetic mechanisms underlying the role of brain-derived neurotrophic factor in depression and response to antidepressants. J Exp Biol 218:21\u201331","journal-title":"J Exp Biol"},{"key":"4495_CR33","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0301-0082(92)90038-G","volume":"38","author":"Y Dumont","year":"1992","unstructured":"Dumont Y, Martel JC, Fournier A, St-Pierre S, Quirion R (1992) Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues. Prog Neurobiol 38:125\u2013167","journal-title":"Prog Neurobiol"},{"key":"4495_CR34","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.npep.2007.10.005","volume":"42","author":"DR Gehlert","year":"2008","unstructured":"Gehlert DR, Thompson LK, Hemrick-Luecke SK, Shaw J (2008) Monoaminergic compensation in the neuropeptide Y deficient mouse brain. Neuropeptides 42:367\u2013375","journal-title":"Neuropeptides"},{"key":"4495_CR35","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jad.2011.03.042","volume":"133","author":"RA Gittins","year":"2011","unstructured":"Gittins RA, Harrison PJ (2011) A morphometric study of glia and neurons in the anterior cingulate cortex in mood disorder. J Affect Disord 133:328\u2013332","journal-title":"J Affect Disord"},{"key":"4495_CR36","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0024-3205(86)90061-5","volume":"38","author":"TS Gray","year":"1986","unstructured":"Gray TS, Morley JE (1986) Neuropeptide Y: anatomical distribution and possible function in mammalian nervous system. Life Sci 38:389\u2013401","journal-title":"Life Sci"},{"key":"4495_CR37","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1476-5381.1994.tb17055.x","volume":"113","author":"S Greber","year":"1994","unstructured":"Greber S, Schwarzer C, Sperk G (1994) Neuropeptide Y inhibits potassium-stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro. Br J Pharmacol 113:737\u2013740","journal-title":"Br J Pharmacol"},{"key":"4495_CR38","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0306-4522(00)00308-0","volume":"100","author":"KL Grove","year":"2000","unstructured":"Grove KL, Campbell RE, Ffrench-Mullen JM, Cowley MA, Smith MS (2000) Neuropeptide Y Y5 receptor protein in the cortical\/limbic system and brainstem of the rat: expression on gamma-aminobutyric acid and corticotropin-releasing hormone neurons. Neuroscience 100:731\u2013740","journal-title":"Neuroscience"},{"key":"4495_CR39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1365-2818.1999.00457.x","volume":"193","author":"HJ Gundersen","year":"1999","unstructured":"Gundersen HJ, Jensen EB, Ki\u00eau K, Nielsen J (1999) The efficiency of systematic sampling in stereology\u2014reconsidered. J Microsc 193:199\u2013211","journal-title":"J Microsc"},{"key":"4495_CR40","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.molmed.2006.12.005","volume":"13","author":"MM Halassa","year":"2007","unstructured":"Halassa MM, Fellin T, Haydon PG (2007) The tripartite synapse: roles for gliotransmission in health and disease. Trends Mol Med 13:54\u201363","journal-title":"Trends Mol Med"},{"key":"4495_CR41","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.brainresrev.2009.05.005","volume":"61","author":"K Hashimoto","year":"2009","unstructured":"Hashimoto K (2009) Emerging role of glutamate in the pathophysiology of major depressive disorder. Brain Res Rev 61:105\u2013123","journal-title":"Brain Res Rev"},{"key":"4495_CR42","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.biopsych.2007.03.017","volume":"62","author":"K Hashimoto","year":"2007","unstructured":"Hashimoto K, Sawa A, Iyo M (2007) Increased levels of glutamate in brains from patients with mood disorders. Biol Psychiatry 62:1310\u20131316","journal-title":"Biol Psychiatry"},{"key":"4495_CR43","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0022-3956(03)00101-8","volume":"38","author":"M Heilig","year":"2004","unstructured":"Heilig M, Zachrisson O, Thorsell A, Ehnvall A, Mottagui-Tabar S, Sj\u00f6gren M, Asberg M, Ekman R, Wahlestedt C, Agren H (2004) Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism. J Psychiatr Res 38:113\u2013121","journal-title":"J Psychiatr Res"},{"key":"4495_CR44","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/hipo.20264","volume":"17","author":"H Ishida","year":"2007","unstructured":"Ishida H, Shirayama Y, Iwata M, Katayama S, Yamamoto A, Kawahara R, Nakagome K (2007) Infusion of neuropeptide Y into CA3 region of hippocampus produces antidepressant-like effect via Y1 receptor. Hippocampus 17:271\u2013280","journal-title":"Hippocampus"},{"key":"4495_CR45","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0166-4328(00)00142-X","volume":"111","author":"PA Jim\u00e9nez-Vasquez","year":"2000","unstructured":"Jim\u00e9nez-Vasquez PA, Salmi P, Ahlenius S, Math\u00e9 AA (2000a) Neuropeptide Y in brains of the flinders sensitive line rat, a model of depression. Effects of electroconvulsive stimuli and d-amphetamine on peptide concentrations and locomotion. Behav Brain Res 111:115\u2013123","journal-title":"Behav Brain Res"},{"key":"4495_CR46","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0022-3956(00)00036-4","volume":"34","author":"PA Jim\u00e9nez-Vasquez","year":"2000","unstructured":"Jim\u00e9nez-Vasquez PA, Overstreet DH, Math\u00e9 AA (2000b) Neuropeptide Y in male and female brains of flinders sensitive line, a rat model of depression. Effects of electroconvulsive stimuli J Psychiatr Res 34:405\u2013412","journal-title":"Effects of electroconvulsive stimuli J Psychiatr Res"},{"key":"4495_CR47","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF00345492","volume":"232","author":"JS Kim","year":"1982","unstructured":"Kim JS, Schmid-Burgk W, Claus D, Kornhuber HH (1982) Increased serum glutamate in depressed patients. Arch Psychiatr Nervenkr 232:299\u2013304","journal-title":"Arch Psychiatr Nervenkr"},{"key":"4495_CR48","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1046\/j.1471-4159.1999.0730641.x","volume":"73","author":"PJ King","year":"1999","unstructured":"King PJ, Widdowson PS, Doods HN, Williams G (1999) Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices. J Neurochem 73:641\u2013646","journal-title":"J Neurochem"},{"key":"4495_CR49","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0169-328X(99)00191-6","volume":"72","author":"J Kopp","year":"1999","unstructured":"Kopp J, Nanobashvili A, Kokaia Z, Lindvall O, H\u00f6kfelt T (1999) Differential regulation of mRNAs for neuropeptide Y and its receptor subtypes in widespread areas of the rat limbic system during kindling epileptogenesis. Brain Res Mol Brain Res 72:17\u201329","journal-title":"Brain Res Mol Brain Res"},{"key":"4495_CR50","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.npep.2013.10.014","volume":"47","author":"V Kormos","year":"2013","unstructured":"Kormos V, Gaszner B (2013) Role of neuropeptides in anxiety, stress, and depression: from animals to humans. Neuropeptides 47:401\u2013419","journal-title":"Neuropeptides"},{"key":"4495_CR51","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00002826-198212000-00002","volume":"5","author":"R Kurlan","year":"1982","unstructured":"Kurlan R, Shoulson I (1982) Up and down regulation: clinical significance of nervous system receptor-drug interactions. Clin Neuropharmacol 5:345\u2013350","journal-title":"Clin Neuropharmacol"},{"key":"4495_CR52","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejphar.2007.08.050","volume":"578","author":"MH Larsen","year":"2008","unstructured":"Larsen MH, Hay-Schmidt A, R\u00f8nn LC, Mikkelsen JD (2008) Temporal expression of brain-derived neurotrophic factor (BDNF) mRNA in the rat hippocampus after treatment with selective and mixed monoaminergic antidepressants. Eur J Pharmacol 578:114\u2013122","journal-title":"Eur J Pharmacol"},{"key":"4495_CR53","doi-asserted-by":"crossref","first-page":"15329","DOI":"10.18632\/oncotarget.7855","volume":"7","author":"L Li","year":"2016","unstructured":"Li L, Deng J, Liu C, Luo H, Guan Y, Zhou J, Qi X, Li T, Xu ZD, Luan GM (2016) Altered expression of neuropeptide Y receptors caused by focal cortical dysplasia in human intractable epilepsy. Oncotarget 7:15329\u201315338","journal-title":"Oncotarget"},{"key":"4495_CR54","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejphar.2013.04.008","volume":"711","author":"LF Li","year":"2013","unstructured":"Li LF, Yang J, Ma SP, Qu R (2013) Magnolol treatment reversed the glial pathology in an unpredictable chronic mild stress-induced rat model of depression. Eur J Pharmacol 711:42\u201349","journal-title":"Eur J Pharmacol"},{"key":"4495_CR55","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.euroneuro.2009.06.010","volume":"19","author":"Q Liu","year":"2009","unstructured":"Liu Q, Li B, Zhu HY, Wang YQ, Yu J, Wu GC (2009) Clomipramine treatment reversed the glial pathology in a chronic unpredictable stress-induced rat model of depression. Eur Neuropsychopharmacol 19:796\u2013805","journal-title":"Eur Neuropsychopharmacol"},{"key":"4495_CR56","first-page":"33","volume-title":"GABA and mood disorders. Experimental and clinical research, vol. 4","author":"KG Lloyd","year":"1986","unstructured":"Lloyd KG, Thuret F, Pilc A (1986) GABA and the mechanism of action of antidepressant drugs. In: Bartholini G, Lloyd KG, Morselli PL (eds) GABA and mood disorders. Experimental and clinical research, vol. 4. Raven Press, New York, pp. 33\u201342"},{"key":"4495_CR57","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.pnpbp.2015.01.008","volume":"59","author":"LM Manosso","year":"2015","unstructured":"Manosso LM, Moretti M, Ribeiro CM, Gon\u00e7alves FM, Leal RB, Rodrigues AL (2015) Antidepressant-like effect of zinc is dependent on signaling pathways implicated in BDNF modulation. Prog Neuro-Psychopharmacol Biol Psychiatry 59:59\u201367","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"4495_CR58","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0165-6147(91)90610-5","volume":"12","author":"MC Michel","year":"1991","unstructured":"Michel MC (1991) Receptors for neuropeptide Y: multiple subtypes and multiple second messengers. Trends Pharmacol Sci 12:389\u2013394","journal-title":"Trends Pharmacol Sci"},{"key":"4495_CR59","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0031-6997(24)01352-8","volume":"50","author":"MC Michel","year":"1998","unstructured":"Michel MC, Beck-Sickinger A, Cox H, Doods HN, Herzog H, Larhammar D, Quirion R, Schwartz T, Westfall T (1998) XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev 50:143\u2013150","journal-title":"Pharmacol Rev"},{"key":"4495_CR60","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0006-3223(00)00999-9","volume":"48","author":"JJ Miguel-Hidalgo","year":"2000","unstructured":"Miguel-Hidalgo JJ, Baucom C, Dilley G, Overholser JC, Meltzer HY, Stockmeier CA, Rajkowska G (2000) Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder. Biol Psychiatry 48:861\u2013873","journal-title":"Biol Psychiatry"},{"key":"4495_CR61","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1007\/s00213-014-3475-8","volume":"231","author":"T Mikoteit","year":"2014","unstructured":"Mikoteit T, Beck J, Eckert A, Hemmeter U, Brand S, Bischof R, Holsboer-Trachsler E, Delini-Stula A (2014) High baseline BDNF serum levels and early psychopathological improvement are predictive of treatment outcome in major depression. Psychopharmacology 231:2955\u20132965","journal-title":"Psychopharmacology"},{"key":"4495_CR62","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.pnpbp.2006.03.036","volume":"30","author":"H Mitani","year":"2006","unstructured":"Mitani H, Shirayama Y, Yamada T, Maeda K, Ashby CR Jr, Kawahara R (2006) Correlation between plasma levels of glutamate, alanine and serine with severity of depression. Prog Neuro-Psychopharmacol Biol Psychiatry 30:1155\u20131158","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"4495_CR63","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/mp.2013.105","volume":"19","author":"ML Molendijk","year":"2014","unstructured":"Molendijk ML, Spinhoven P, Polak M, Bus BA, Penninx BW, Elzinga BM (2014) Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N\u00a0=\u00a09484). Mol Psychiatry 19:791\u2013800","journal-title":"Mol Psychiatry"},{"key":"4495_CR64","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neuropharm.2011.06.030","volume":"62","author":"JC Morales-Medina","year":"2012","unstructured":"Morales-Medina JC, Dumont Y, Benoit CE, Bastianetto S, Flores G, Fournier A, Quirion R (2012a) Role of neuropeptide Y Y1 and Y2 receptors on behavioral despair in a rat model of depression with co-morbid anxiety. Neuropharmacology 62:200\u2013208","journal-title":"Neuropharmacology"},{"key":"4495_CR65","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.npep.2012.09.009","volume":"46","author":"JC Morales-Medina","year":"2012","unstructured":"Morales-Medina JC, Dumont Y, Bonaventure P, Quirion R (2012b) Chronic administration of the Y2 receptor antagonist, JNJ-31020028, induced anti-depressant like-behaviors in olfactory bulbectomized rat. Neuropeptides 46:329\u2013334","journal-title":"Neuropeptides"},{"key":"4495_CR66","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.brainres.2009.09.077","volume":"1314","author":"JC Morales-Medina","year":"2010","unstructured":"Morales-Medina JC, Dumont Y, Quirion R (2010) A possible role of neuropeptide Y in depression and stress. Brain Res 1314:194\u2013205","journal-title":"Brain Res"},{"key":"4495_CR67","doi-asserted-by":"crossref","first-page":"13290","DOI":"10.1073\/pnas.95.22.13290","volume":"95","author":"D Ong\u00fcr","year":"1998","unstructured":"Ong\u00fcr D, Drevets WC, Price JL (1998) Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A 95:13290\u201313295","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4495_CR68","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.neubiorev.2005.03.015","volume":"29","author":"DH Overstreet","year":"2005","unstructured":"Overstreet DH, Friedman E, Math\u00e9 AA, Yadid G (2005) The flinders sensitive line rat: a selectively bred putative animal model of depression. Neurosci Biobehav Rev 29:739\u2013759","journal-title":"Neurosci Biobehav Rev"},{"key":"4495_CR69","doi-asserted-by":"crossref","first-page":"5436","DOI":"10.1016\/j.bmcl.2011.06.124","volume":"21","author":"M Packiarajan","year":"2011","unstructured":"Packiarajan M, Marzabadi MR, Desai M, Lu Y, Noble SA, Wong WC, Jubian V, Chandrasena G, Wolinsky TD, Zhong H, Walker MW, Wiborg O, Andersen K (2011) Discovery of Lu AA33810: a highly selective and potent NPY5 antagonist with in vivo efficacy in a model of mood disorder. Bioorg Med Chem Lett 21:5436\u20135441","journal-title":"Bioorg Med Chem Lett"},{"key":"4495_CR70","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1601-183X.2008.00389.x","volume":"7","author":"E Painsipp","year":"2008","unstructured":"Painsipp E, Wultsch T, Edelsbrunner ME, Tasan RO, Singewald N, Herzog H, Holzer P (2008) Reduced anxiety-like and depression-related behavior in neuropeptide Y Y4 receptor knockout mice. Genes Brain Behav 7:532\u2013542","journal-title":"Genes Brain Behav"},{"key":"4495_CR71","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1196\/annals.1300.016","volume":"1003","author":"IA Paul","year":"2003","unstructured":"Paul IA, Skolnick P (2003) Glutamate and depression: clinical and preclinical studies. Ann N Y Acad Sci 1003:250\u2013272","journal-title":"Ann N Y Acad Sci"},{"key":"4495_CR72","volume-title":"The rat brain in stereotaxic coordinates","author":"G Paxinos","year":"1986","unstructured":"Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press, San Diego","edition":"2"},{"key":"4495_CR73","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/BF00166895","volume":"354","author":"P Pokk","year":"1996","unstructured":"Pokk P, Kivastik T, Sobol D, Liljequist S, Zharkovsky A (1996) Is upregulation of benzodiazepine receptors a compensatory reaction to reduced GABAergic tone in the brain of stressed mice? Naunyn Schmiedeberg's Arch Pharmacol 354:703\u2013708","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"4495_CR74","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jad.2014.11.044","volume":"174","author":"M Polyakova","year":"2015","unstructured":"Polyakova M, Stuke K, Schuemberg K, Mueller K, Schoenknecht P, Schroeter ML (2015) BDNF as a biomarker for successful treatment of mood disorders: a systematic & quantitative meta-analysis. J Affect Disord 174:432\u2013440","journal-title":"J Affect Disord"},{"key":"4495_CR75","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","volume":"47","author":"RD Porsolt","year":"1978","unstructured":"Porsolt RD, Anton G, Blavet N, Jalfre M (1978) Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47:379\u2013391","journal-title":"Eur J Pharmacol"},{"key":"4495_CR76","first-page":"327","volume":"229","author":"RD Porsolt","year":"1977","unstructured":"Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229:327\u2013336","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"4495_CR77","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1517\/13543784.2011.594039","volume":"20","author":"J Prins","year":"2011","unstructured":"Prins J, Olivier B, Korte SM (2011) Triple reuptake inhibitors for treating subtypes of major depressive disorder: the monoamine hypothesis revisited. Expert Opin Investig Drugs 20:1107\u20131130","journal-title":"Expert Opin Investig Drugs"},{"key":"4495_CR78","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0006-3223(00)00950-1","volume":"48","author":"G Rajkowska","year":"2000","unstructured":"Rajkowska G (2000) Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiatry 48:766\u2013777","journal-title":"Biol Psychiatry"},{"key":"4495_CR79","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0006-3223(01)01080-0","volume":"49","author":"G Rajkowska","year":"2001","unstructured":"Rajkowska G, Halaris A, Selemon LD (2001) Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol Psychiatry 49:741\u2013752","journal-title":"Biol Psychiatry"},{"key":"4495_CR80","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0006-3223(99)00041-4","volume":"45","author":"G Rajkowska","year":"1999","unstructured":"Rajkowska G, Miguel-Hidalgo JJ, Wei J, Dilley G, Pittman SD, Meltzer HY, Overholser JC, Roth BL, Stockmeier CA (1999) Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 45:1085\u20131098","journal-title":"Biol Psychiatry"},{"key":"4495_CR81","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0893-133X(01)00403-1","volume":"26","author":"JP Redrobe","year":"2002","unstructured":"Redrobe JP, Dumont Y, Fournier A, Quirion R (2002) The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test. Neuropsychopharmacology 26:615\u2013624","journal-title":"Neuropsychopharmacology"},{"key":"4495_CR82","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1523\/JNEUROSCI.23-01-00349.2003","volume":"23","author":"T Saarelainen","year":"2003","unstructured":"Saarelainen T, Hendolin P, Lucas G, Koponen E, Sairanen M, MacDonald E, Agerman K, Haapasalo A, Nawa H, Aloyz R, Ernfors P, Castr\u00e9n E (2003) Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J Neurosci 23:349\u2013357","journal-title":"J Neurosci"},{"key":"4495_CR83","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ddstr.2008.10.003","volume":"5","author":"HD Schmidt","year":"2008","unstructured":"Schmidt HD, Banasr M, Duman RS (2008) Future antidepressant targets: neurotrophic factors and related signaling cascades. Drug Discov Today Ther Strateg 5:151\u2013156","journal-title":"Drug Discov Today Ther Strateg"},{"key":"4495_CR84","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1023\/A:1022397704922","volume":"28","author":"A Schousboe","year":"2003","unstructured":"Schousboe A (2003) Role of astrocytes in the maintenance and modulation of glutamatergic and GABAergic neurotransmission. Neurochem Res 28:347\u2013352","journal-title":"Neurochem Res"},{"key":"4495_CR85","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1471-4159.2004.03005.x","volume":"93","author":"AP Silva","year":"2005","unstructured":"Silva AP, Xapelli S, Pinheiro PS, Ferreira R, Louren\u00e7o J, Crist\u00f3v\u00e3o A, Grouzmann E, Cavadas C, Oliveira CR, Malva JO (2005) Up-regulation of neuropeptide Y levels and modulation of glutamate release through neuropeptide Y receptors in the hippocampus of kainate-induced epileptic rats. J Neurochem 93:163\u2013170","journal-title":"J Neurochem"},{"key":"4495_CR86","first-page":"1","volume":"18","author":"L Soleimani","year":"2014","unstructured":"Soleimani L, Oquendo MA, Sullivan GM, Math\u00e9 AA, Mann JJ (2014) Cerebrospinal fluid neuropeptide Y levels in major depression and reported childhood trauma. Int J Neuropsychopharmacol 18:1\u20136","journal-title":"Int J Neuropsychopharmacol"},{"key":"4495_CR87","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2818.1984.tb02501.x","volume":"134","author":"DC Sterio","year":"1984","unstructured":"Sterio DC (1984) The unbiased estimation of number and sizes of arbitrary particles using the disector. J Microsc 134:127\u2013136","journal-title":"J Microsc"},{"key":"4495_CR88","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1016\/S0014-2999(99)00800-6","volume":"387","author":"KA Stogner","year":"2000","unstructured":"Stogner KA, Holmes PV (2000) Neuropeptide-Y exerts antidepressant-like effects in the forced swim test in rats. Eur J Pharmacol 387:R9\u201310","journal-title":"Eur J Pharmacol"},{"key":"4495_CR89","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/10284150412331281040","volume":"7","author":"A Stricker-Krongrad","year":"2004","unstructured":"Stricker-Krongrad A, Beck B (2004) Up-regulation of neuropeptide Y receptors in the hypothalamus of monosodium glutamate-lesioned Sprague-Dawley rats. Nutr Neurosci 7:241\u2013245","journal-title":"Nutr Neurosci"},{"key":"4495_CR90","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.neuropharm.2015.08.026","volume":"99","author":"B Szewczyk","year":"2015","unstructured":"Szewczyk B, Pochwat B, Rafa\u0142o A, Palucha-Poniewiera A, Domin H, Nowak G (2015) Activation of mTOR dependent signaling pathway is a necessary mechanism of antidepressant-like activity of zinc. Neuropharmacology 99:517\u2013526","journal-title":"Neuropharmacology"},{"key":"4495_CR91","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.pnpbp.2008.12.011","volume":"33","author":"B Szewczyk","year":"2009","unstructured":"Szewczyk B, Poleszak E, Wla\u017a P, Wr\u00f3bel A, Blicharska E, Cichy A, Dyba\u0142a M, Siwek A, Pomierny-Chamio\u0142o L, Piotrowska A, Bra\u0144ski P, Pilc A, Nowak G (2009) The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test. Prog Neuro-Psychopharmacol Biol Psychiatry 33:323\u2013329","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"4495_CR92","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.neuroscience.2008.11.048","volume":"158","author":"RO Tasan","year":"2009","unstructured":"Tasan RO, Lin S, Hetzenauer A, Singewald N, Herzog H, Sperk G (2009) Increased novelty-induced motor activity and reduced depression-like behavior in neuropeptide Y (NPY)-Y4 receptor knockout mice. Neuroscience 158:1717\u20131730","journal-title":"Neuroscience"},{"key":"4495_CR93","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.tins.2015.03.003","volume":"38","author":"SM Thompson","year":"2015","unstructured":"Thompson SM, Kallarackal AJ, Kvarta MD, Van Dyke AM, LeGates TA, Cai X (2015) An excitatory synapse hypothesis of depression. Trends Neurosci 38:279\u2013294","journal-title":"Trends Neurosci"},{"key":"4495_CR94","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1124\/jpet.108.144634","volume":"328","author":"MW Walker","year":"2009","unstructured":"Walker MW, Wolinsky TD, Jubian V, Chandrasena G, Zhong H, Huang X, Miller S, Hegde LG, Marsteller DA, Marzabadi MR, Papp M, Overstreet DH, Gerald CP, Craig DA (2009) The novel neuropeptide Y Y5 receptor antagonist Lu AA33810 [N-[[trans-4-[(4,5-dihydro[1] benzothiepino [5,4-d] thiazol-2-yl) amino] cyclohexyl] methyl]-methanesulfonamide] exerts anxiolytic- and antidepressant-like effects in rat models of stress sensitivity. J Pharmacol Exp Ther 328:900\u2013911","journal-title":"J Pharmacol Exp Ther"},{"key":"4495_CR95","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/(SICI)1096-9861(19960617)370:1<11::AID-CNE2>3.0.CO;2-O","volume":"370","author":"MJ West","year":"1996","unstructured":"West MJ, Ostergaard K, Andreassen OA, Finsen B (1996) Estimation of the number of somatostatin neurons in the striatum: an in situ hybridization study using the optical fractionator method. J Comp Neurol 370:11\u201322","journal-title":"J Comp Neurol"},{"key":"4495_CR96","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0924-977X(98)00026-1","volume":"9","author":"A Westrin","year":"1999","unstructured":"Westrin A, Ekman R, Tr\u00e4skman-Bendz L (1999) Alterations of corticotropin releasing hormone (CRH) and neuropeptide Y (NPY) plasma levels in mood disorder patients with a recent suicide attempt. Eur Neuropsychopharmacol 9:205\u2013211","journal-title":"Eur Neuropsychopharmacol"},{"key":"4495_CR97","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0022-3956(88)90030-1","volume":"22","author":"E Widerl\u00f6v","year":"1988","unstructured":"Widerl\u00f6v E, Lindstr\u00f6m LH, Wahlestedt C, Ekman R (1988) Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively. J Psychiatr Res 22:69\u201379","journal-title":"J Psychiatr Res"},{"key":"4495_CR98","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neuint.2009.02.019","volume":"55","author":"JM Wiero\u0144ska","year":"2009","unstructured":"Wiero\u0144ska JM, Pilc A (2009) Metabotropic glutamate receptors in the tripartite synapse as a target for new psychotropic drugs. Neurochem Int 55:85\u201397","journal-title":"Neurochem Int"},{"key":"4495_CR99","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1517\/14728222.2011.628314","volume":"15","author":"G Wu","year":"2011","unstructured":"Wu G, Feder A, Wegener G, Bailey C, Saxena S, Charney D, Math\u00e9 AA (2011) Central functions of neuropeptide Y in mood and anxiety disorders. Expert Opin Ther Targets 15:1317\u20131331","journal-title":"Expert Opin Ther Targets"},{"key":"4495_CR100","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.pbb.2012.08.020","volume":"103","author":"AL Zeni","year":"2012","unstructured":"Zeni AL, Zomkowski AD, Maraschin M, Rodrigues AL, Tasca CI (2012) Involvement of PKA, CaMKII, PKC, MAPK\/ERK and PI3K in the acute antidepressant-like effect of ferulic acid in the tail suspension test. Pharmacol Biochem Behav 103:181\u2013186","journal-title":"Pharmacol Biochem Behav"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-016-4495-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-016-4495-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-016-4495-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T15:25:49Z","timestamp":1749828349000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-016-4495-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,14]]},"references-count":100,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["4495"],"URL":"https:\/\/doi.org\/10.1007\/s00213-016-4495-3","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,14]]}}}